ES2039377T3 - Un supositorio. - Google Patents

Un supositorio.

Info

Publication number
ES2039377T3
ES2039377T3 ES198787108631T ES87108631T ES2039377T3 ES 2039377 T3 ES2039377 T3 ES 2039377T3 ES 198787108631 T ES198787108631 T ES 198787108631T ES 87108631 T ES87108631 T ES 87108631T ES 2039377 T3 ES2039377 T3 ES 2039377T3
Authority
ES
Spain
Prior art keywords
weight
suppository
suppositories
years
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787108631T
Other languages
English (en)
Spanish (es)
Inventor
Yamashita Chikamasa
Ishida 48-12 Aza-Nishinosu Kouzo
Gohachiro Miyamoto
Ishikawa Muneyoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Reckitt and Colman Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt and Colman Products Ltd filed Critical Reckitt and Colman Products Ltd
Application granted granted Critical
Publication of ES2039377T3 publication Critical patent/ES2039377T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES198787108631T 1986-06-16 1987-06-16 Un supositorio. Expired - Lifetime ES2039377T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61141086A JPS62298530A (ja) 1986-06-16 1986-06-16 坐薬用医薬組成物

Publications (1)

Publication Number Publication Date
ES2039377T3 true ES2039377T3 (es) 1993-10-01

Family

ID=15283879

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787108631T Expired - Lifetime ES2039377T3 (es) 1986-06-16 1987-06-16 Un supositorio.

Country Status (10)

Country Link
US (1) US4784855A (enExample)
EP (1) EP0253143B1 (enExample)
JP (1) JPS62298530A (enExample)
AT (1) ATE67932T1 (enExample)
CA (1) CA1283605C (enExample)
DE (1) DE3773440D1 (enExample)
DK (1) DK167559B1 (enExample)
ES (1) ES2039377T3 (enExample)
IE (1) IE59668B1 (enExample)
PT (1) PT85086B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989009066A1 (en) * 1988-03-24 1989-10-05 Bukh Meditec A/S Controlled release composition
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
JP2007016052A (ja) * 1998-03-03 2007-01-25 Eisai R & D Management Co Ltd 抗痴呆薬を含有した経皮適用製剤又は坐剤
WO2004054554A1 (en) * 2002-12-13 2004-07-01 Euro-Celtique S.A. Transdermal buprenorphine to treat pain in sickle cell crisis
US7135436B2 (en) * 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
US9415034B2 (en) * 2005-01-05 2016-08-16 National Defense Medical Center Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
WO2008153611A2 (en) 2007-05-25 2008-12-18 Qlt Usa, Inc. Sustained delivery formulations of risperidone compounds
GB2481017B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
WO2018165183A1 (en) * 2017-03-06 2018-09-13 Tactus Therapeutics, Inc. Abuse deterrent opioid formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870061A (en) * 1956-11-08 1959-01-20 Mead Johnson & Co Concentrates of dialkyl sulfosuccinates
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
DE2229770A1 (de) * 1972-06-19 1974-01-10 Boehringer Sohn Ingelheim N-(heteroarylmethyl)-7alpha-acyl6,14-endoaethenotetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
US4004010A (en) * 1972-06-19 1977-01-18 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing an N-(furyl-methyl)-7α-acyl-6,14-(endoetheno or endoethano)-tetrahydro-nororipavine or -northebaine and method of use
DE2230154A1 (de) * 1972-06-21 1974-01-17 Boehringer Sohn Ingelheim N-(heteroaryl-methyl)-6,14-endoaetheno7alpha-hydroxyalkyl-tetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
JPS54157820A (en) * 1978-05-30 1979-12-13 Res Inst For Prod Dev Preparation of multi-layered suppository base
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
GB8332556D0 (en) * 1983-12-06 1984-01-11 Reckitt & Colmann Prod Ltd Analgesic compositions
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4699776A (en) * 1985-06-28 1987-10-13 R. P. Scherer Corporation Suppositories containing analgesics, antipyretics or anti-inflammatory agents

Also Published As

Publication number Publication date
CA1283605C (en) 1991-04-30
JPS62298530A (ja) 1987-12-25
DE3773440D1 (de) 1991-11-07
IE871522L (en) 1987-12-16
JPH0475889B2 (enExample) 1992-12-02
IE59668B1 (en) 1994-03-09
EP0253143B1 (en) 1991-10-02
DK167559B1 (da) 1993-11-22
ATE67932T1 (de) 1991-10-15
EP0253143A3 (en) 1989-08-23
DK305087A (da) 1987-12-17
US4784855A (en) 1988-11-15
DK305087D0 (da) 1987-06-16
PT85086A (en) 1987-07-01
PT85086B (pt) 1990-03-08
EP0253143A2 (en) 1988-01-20

Similar Documents

Publication Publication Date Title
ES2076935T3 (es) Compuesto de pirazolopiridina y procedimientos para su preparacion.
ES2039377T3 (es) Un supositorio.
SE8602723L (sv) Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem
ES2058527T3 (es) Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen.
ES2196377T3 (es) Derivados de naftiridina.
ATE61050T1 (de) Pyridazinamine wirksam gegen viren.
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES2054860T5 (es) Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos.
ES2169105T3 (es) Agentes antitromboticos tripeptidicos.
ATE67084T1 (de) Mittel zur mundhygiene.
LU90283I2 (fr) Sporanox soluté buvable et ses dérivés pharmaceutiquement acceptables
BR0010476A (pt) Compostos derivados do 4,5,6,7-tetrahidroindazol e seu uso como agentes antitumorais
ES2038643T3 (es) Procedimiento para la obtencion de una composicion farmaceutica topica.
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
MX9300779A (es) 3-(1h-tetrazol-5-y1)-4h-pyrido[1,2-a]pirimidina-4-onas composiciones farmaceuticas que las contienen y su preparacion de las mismas
ES2043665T3 (es) 6,11-dihidro-11-(4-piperidiliden)-5h-benzo-(5,6)-ciclohepta-(1,2-b)-piridinas y composiciones y metodos de uso.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
EP0153152A3 (en) (2-oxo-1,2,3,5-tetrahydroimidazo-/2,1-b/quinnazolinyl)-oxyalkylamides, their preparation, compositions containing them and their use in making medicaments
ES2109229T3 (es) Sulfonamidas sustituidas y compuestos relacionados para el tratamiento del asma, la artritis y enfermedades relacionadas.
SE8302979L (sv) Piperazinderivat, deras framstellning och farmaceutiska kompositioner innehallande dessa
ES2059130T3 (es) Composiciones farmaceuticas que contienen ipriflavona, procedimiento para su preparacion y uso terapeutico relacionado.
FI803202L (fi) Fosfonohydroxiaettiksyra foerfarande foer dess framstaellning och dess anvaendning saosom laekemedel

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 253143

Country of ref document: ES